Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

Thumbnail

Poverty can change the wiring of a child's brain, MRI study suggests

New research out of the Washington University School of Medicine in St. Louis is offering new insight into how childhood struggles can affect brain development and connectivity. 

molecular imaging study on brain connections in obese individuals

Obesity linked to altered brain connectivity on PET/MRI exams

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  

SNMMI Image of the Year

SNMMI unveils Image of the Year

This year the Henry N. Wagner Jr., Image of the Year is actually a group of images displaying the efficacy of a 68Ga-DOTA-5G and 177Lu-DOTA-ABM-5G theranostic pairing that improves the detection and treatment of metastatic pancreatic cancer. 

Syringeless contrast media injectors like the GE Ulrich CT Motion have gained a lot of interest in 2022 because of the iodine contrast shortage. These systems use rollers to squeeze precise amounts of contrast from a large bolus container for multiple patients, helping conserve a significant amount of contrast.

Multi-use syringeless injectors could completely eliminate contrast waste

Such products could increase departmental efficiency and advance environmental initiatives in radiology, experts claimed in Academic Radiology.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

MRA for pulmonary embolus

MR angiography a suitable alternative to CT when ruling out pulmonary embolus

The modality switch became especially important during the iodinated contrast shortage of 2022 when clinics were forced to deploy mitigation tactics as a means of preserving their contrast supply. 

Thumbnail

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.